ctrl K

Mural Oncology (MURA)

NASDAQ: MURA · Real-Time Price · USD

2.63

0.01 (0.38%)

At close: Apr 30, 2025, 3:59 PM

2.68

2.10%

After-hours: Apr 30, 2025, 04:40 PM EDT

Mural Oncology Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	2.57M	1.54M	1.47M
Gross Profit	n/a	-2.57M	-1.54M	-1.47M
Operating Income	n/a	-194.64M	-195.15M	-175.37M
Interest Income	n/a	n/a	n/a	n/a
Pretax Income	-128.51M	-195.29M	-195.15M	-175.37M
Net Income	-128.51M	-207.45M	-200.03M	-175.43M
Selling & General & Admin	27.6M	30.04M	25.08M	15.55M
Research & Development	110.67M	162.03M	170.07M	159.82M
Other Expenses	n/a	n/a	n/a	n/a
Operating Expenses	138.26M	192.07M	195.15M	175.37M
Interest Expense	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	-667K	n/a	n/a
Cost & Expenses	n/a	194.64M	195.15M	175.37M
Income Tax Expense	n/a	12.16M	4.88M	68K
Shares Outstanding (Basic)	16.95M	16.69M	16.69M	16.69M
Shares Outstanding (Diluted)	16.95M	16.69M	16.69M	16.69M
EPS (Basic)	-7.58	-12.43	-11.99	-10.51
EPS (Diluted)	-7.58	-12.43	-11.99	-10.51
EBITDA	n/a	-192.72M	-183.38M	-173.89M
EBIT	n/a	-195.29M	-184.92M	-175.37M
Depreciation & Amortization	n/a	2.57M	1.54M	1.47M